1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: generic
Denis Chem Lab Ltd.

Denis Chem Lab Ltd.

BBSE:DENISCHEM
60.02
INR
-1.06
(-1.74%)
5.76EPS
13.03P/E
1.04BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
211.49
80.5
104.39
95.78
84.77
89.44
97.98
78.65
98.36
115.88
120.93
124.88
130.95
131.64
Basic EPS, GAAP
3.92
0.09
-4.66
1.05
1.69
4.58
3.04
1.63
4.51
5.66
8.04
5.82
6.06
5.76
Free Cash Flow per Basic Share
-38.01
-15.02
8.61
3.91
8.39
5.74
9.64
5.74
12.3
11.77
12.84
8.71
2.98
- -
Dividend per Share
1.11
- -
0.01
- -
- -
- -
1.21
- -
0.75
1.5
2
2.5
1.5
- -
Book Value per Share
29.72
17.65
17.25
24.08
35.98
40.69
42.58
44.32
47.89
52.08
57.91
61.33
65.99
- -
Tangible Book Value per Share
29.72
17.53
17.1
23.97
35.82
40.55
42.47
44.22
47.68
51.92
57.79
61.25
65.91
- -
Basic Weighted Avg Shares
3
10
10
12
13
14
14
14
14
14
14
14
14
14
Sales/Revenue/Turnover
673
769
996
1,125
1,072
1,241
1,360
1,091
1,365
1,608
1,678
1,733
1,817
1,824
Operating Margin (%)
7.32
7.08
2.88
6.51
6.01
6.76
6.61
7.01
8.55
8.17
9.03
6.2
6.69
5.43
Depreciation Expense
13
39
56
68
59
64
67
60
58
78
69
69
68
68
Net Income, GAAP
12
1
-44
12
21
63
42
23
63
79
112
81
84
80
Effective Tax Rate (%)
41.43
77.26
- -
37.1
- -
- -
26.41
26.65
29.5
28
26.28
27.32
29.3
28.91
Profit Margin (%)
1.85
0.11
-4.46
1.1
2
5.12
3.1
2.07
4.59
4.89
6.65
4.66
4.63
4.37
Working Capital
85
-20
-124
35
124
113
157
235
280
352
422
445
537
- -
LT Debt
170
240
199
173
85
48
22
35
22
9
5
5
5
- -
Total Equity
95
168
165
299
499
565
591
615
665
723
804
851
916
- -
Return on Invested Capital (%)
4.06
0.17
- -
1.96
- -
- -
8.09
4.61
9.52
11
13.5
8.42
8.35
- -
Return on Capital (%)
9.02
2.46
- -
7.04
- -
- -
7.9
4.41
9.47
11.23
14.65
9.72
9.63
- -
Return on Common Equity (%)
14.13
0.62
-26.7
5.34
5.37
11.94
7.29
3.76
9.79
11.33
14.62
9.76
9.52
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
37
- -
LT Borrowings
- -
5
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
1,089
785
1,041

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
853
- -
Cash, Cash Equivalents & STI
- -
286
- -
Accounts Receivable, Net
- -
387
- -
Inventories
- -
106
- -
Total Current Liabilities
- -
317
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
37
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.18%
8.3%
7.6%
Free Cash Flow
11.04%
4.21%
-65.83%
Net Income, GAAP
28.22%
44.1%
4.13%
Sales/Revenue/Turnover
6.91%
11.07%
4.86%
Total Cash Common Dividend
- -
- -
-40%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
413
478
428
414
1,733
2026
433
462
455
468
1,817
2027
440
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.5
2.54
1.27
0.51
5.82
2026
1.78
1.6
2.39
0.29
6.06
2027
1.47
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
2.5
2026
- -
- -
- -
- -
1.5
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Nirmal Himanshu Patel
Full Time Employees
156
Sector
Health technology
Industry
Pharmaceuticals: generic
Address
401, Abhishree Complex Gandhi Nagar GU India 380015
IPO Date
Feb 21, 2014
Website
denischemlab.com
Similar Companies
Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (TASE:TEVA)
Jagsonpal Pharmaceuticals Ltd. (NSE:JAGSNPHARM)
Zim Laboratories Ltd. (NSE:ZIMLAB)
Paradigm Biopharmaceuticals Ltd. (ASX:PAR)
Neuren Pharmaceuticals Limited (ASX:NEU)
Business
Denis Chem Lab Limited operates within the pharmaceutical manufacturing industry, focusing on the production and distribution of sterile intravenous solutions in various bottle formats. Its comprehensive product line includes antibiotic and diuretic injections, parenteral amino acid solutions, plasma volume expanders, anti-anaerobic preparations, and irrigation solutions. The company also undertakes contract manufacturing for other pharmaceutical firms. Established on July 15, 1980, Denis Chem Lab Limited is based in Chhatral, Kalol, Gujarat, India.